Actinic Keratoses: A Prospective Pilot Study on a Novel Formulation of 4% 5-Fluorouracil Cream and a Review of Other Current Topical Treatment Options.
Ludovica ToffoliCaterina DianzaniSerena BoninClaudio GuarneriFabrizio GuarneriRoberta GiuffridaIris ZalaudekConforti ClaudioPublished in: Cancers (2023)
In the setting of topical chemotherapy and immunotherapy, the new formulation of 5-FU 4% proved to be a highly effective treatment for AKs and field cancerization.